drugset

drugset / Trial / NCT01118377

A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas

NCT01118377 ↗

Phase 2 Completed 45 enrolled Hoffmann-La Roche Pediatric Brain Tumor Consortium · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study evaluated the effect of capecitabine and concomitant radiation therapy in children with newly diagnosed brainstem gliomas.

Timeline

Start: 2007-05
Primary completion: 2013-01
Completion: 2013-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capecitabine	Small molecule	1250 mg/m2	Oral

Indications